GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] New Zealand — has anyone got a straight answer on glycaemic control — 38 comments in the full submission. View in context.
1.1k
c/t2dglp1·submitted 5 months ago by u/stubborn_batchlist_maybe

[Question] New Zealand — has anyone got a straight answer on glycaemic control

Questionbranch of 5 comments

Week 88 update. 19kg down from the start, early fullness basically gone since about week 45. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness. The part that surprised me is how much of this is…

Read the full submission and all 38 comments →

This branch

5 comments, started 5 months ago
u/teodor_duarte61 points·5 months ago

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

replysharereportpermalink
u/nadia_norgaard40 points·5 months ago

This is correct. Hypo risk is real.

replysharereportpermalink
u/sten_palacios22 points·5 months ago

Not to be pedantic but glycaemic control and CGM are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/teodor_duarte51 points·5 months ago

I love that this community will spend 40 comments on a detail.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/sigrid_kaufmann18 points·5 months ago

Strongly agree. A1c matters as much as weight.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.